Meeting the Demand for New Antibiotics
Nabriva Therapeutics is committed to developing new antibiotics to treat infectious diseases. Our dedicated team includes people with extensive science and industry experience and a shared passion for addressing the increasingly urgent problem of bacterial resistance worldwide.
Nabriva is a clinical-stage biopharmaceutical company with locations in the
United States (King of Prussia, PA, San Diego, CA), Austria (Vienna), and Ireland (Dublin), home of our corporate headquarters.